Both CPT-11, a less toxic prodrug of CPT, and SC-236 significantly reduced the growth of 3LL tumor cells, which constitutively express COX-2 and PGE2 (41), in a CD8+ T cell-dependent manner. The gene discussed is CD8A; the disease is neoplasm.